Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 6:57 PM
Ignite Modification Date: 2025-12-25 @ 4:30 PM
NCT ID: NCT00860457
Description: None
Frequency Threshold: 5
Time Frame: None
Study: NCT00860457
Study Brief: Lenalidomide Following Fludarabine/Rituximab (FR) in Untreated Chronic Lymphocytic Leukemia (CLL)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Chemotherapy Fludarabine/Rituximab followed by Lenalidomide Rituximab: 375 mg/m2 IV infusion Day 1 of each 28-day cycle for maximum of 6 cycles Fludarabine: 25 mg/m2 IV Days 1-5 of each 28-day cycle for maximum of 6 cycles Lenalidomide: 5-10 mg PO daily on Days 1-21 of each 28-day cycle for a maximum of 6 cycles None None 1 22 13 22 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Fatal septic shock secondary to bacteremia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
grade 3/4 anemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
grade 3/4 thrombocytopneia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
grade 1/2 thrombocytopenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
grade 3/4 neutropenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
grade 1/2 anemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
grade 1/2 neutropenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View